LD Micro Invitational
June 7-9, 2016
Luxe Hotel Sunset Boulevard (Los Angeles)
The three-day LD Micro Invitational in Bel Air, California, features company presentations from more than 200 select high-potential small-cap companies spanning multiple industries. Institutional and retail investors in attendance also have access to numerous networking opportunities and social events to learn more about these companies.
Stevia First (STVF)
Stevia First (OTC: STVF) is an agricultural biotech company that has developed expertise for the production of stevia using fermentation and for improvement of traditional stevia farming and processing methods. The company is also applying technologies in software and the life sciences to develop product applications beyond stevia and the food and beverage industry. For more information, visit the company's website at www.steviafirst.com.
Sonic Foundry (SOFO)
Sonic Foundry (NASDAQ: SOFO) provides video capture, management and webcasting solutions to education, business and government entities worldwide. Its patented Mediasite Video Platform transforms communications, training, education and events for more than 3,800 customers in over 65 countries. Sonic Foundry is a leader in Aragon Research's Globe for Enterprise Video and Forrester's Enterprise Video Platforms and Webcasting Wave; Frost & Sullivan's lecture capture leader for seven consecutive years; and a challenger in Gartner's Magic Quadrant for Enterprise Video Content Management. For more information, visit the company's website at www.sonicfoundry.com.
Cavco Industries (CVCO)
Cavco Industries (NASDAQ: CVCO) designs and produces factory-built housing products distributed through a network of independent and company-owned retailers. The company is one of the largest producers of manufactured homes in the United States. Cavco is also a leading producer of park model RVs, vacation cabins, and systems-built commercial structures, as well as modular homes. Cavco's mortgage subsidiary offers conforming mortgages to purchasers of factory-built and site-built homes. It also provides property and casualty insurance to owners of manufactured homes. For more information, visit the company's website at www.cavco.com.
Caladrius Biosciences (CLBS)
Caladrius Biosciences (NASDAQ: CLBS), through its wholly owned subsidiary, PCT, is a leading development and manufacturing partner to the cell therapy industry. Caladrius works with its clients to overcome the fundamental challenges presented by cell therapy manufacturing by providing a wide range of innovative services including product and process development, GMP manufacturing, engineering and automation, cell and tissue processing, logistics, storage and distribution, as well as expert consulting and regulatory support. Around this core expertise, Caladrius strategically develops product candidates, which currently include an innovative therapy for type I diabetes based on a proprietary platform technology for immunomodulation. For more information, visit the company's website at www.caladrius.com.
Quest Solution (QUES)
Quest Solution (OTC: QUES) is a specialty systems integrator focused on field and supply chain mobility. It is also a manufacturer and distributor of consumables (labels, tags, and ribbons), RFID solutions and barcoding printers. Quest specializes in the design, deployment and management of enterprise mobility solutions including Automatic Identification (AIDC), mobile cloud analytics, RFID and proprietary mobility software. Its customers are leading Fortune 500 companies. For more information, visit the company's website at www.questsolution.com.
TIO Networks (TNCGF)
TIO Networks (OTC: TNCGF) is a cloud-based multi-channel bill payment processor serving the largest telecom, wireless, cable and utility bill issuers in North America. TIO integrates its Transaction Processing System to the accounting back-office of its billers, which allows billers to post payments accurately and expeditiously to the appropriate customer accounts. Once integrated with a biller, TIO is able to offer to the billers' customers the ability to pay their accounts through multiple access points. For more information, visit the company's website at www.tionetworks.com.
CytoDyn (OTC: CYDY) is a biotech company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has finished Phase 2 clinical trials with demonstrated antiviral activity in man and is currently in Phase 3. Results from seven Phase 1 and Phase 2 human clinical trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV. A recent Phase 2b clinical trial demonstrated that PRO 140 can prevent viral escape in patients during several weeks of interruption from conventional drug therapy. For more information, visit the company's website at www.cytodyn.com.
The Female Health Company (FHCO)
The Female Health Company (NASDAQ: FHCO) manufactures and markets the FC2 Female Condom® (FC2). The company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in a number of countries around the world. The patents cover key aspects of FC2, including overall design and manufacturing process. The FC2 Female Condom® is the only currently available female-controlled product approved by FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. For more information, visit the company's website at www.femalehealth.com.
Snipp Interactive (SNIPF)
Snipp Interactive's (OTC: SNIPF) incentive marketing technology platform enables brands and retailers to drive customer engagement and purchase. The company has a comprehensive suite of solutions including receipt processing, loyalty, rebates, contests and promotions, rewards, mobile messaging, data analytics and more. SnippCheck, Snipp's unique receipt processing engine, provides receipt-based purchase validation, and has powered several hundred programs for leading Fortune 500 brands and world-class agencies and partners. Snipp is headquartered in Bethesda, Maryland, with offices across the United States, Canada, Ireland, the Middle East and India. For more information, visit the company's website at www.wp.snipp.com.
Aeolus Pharmaceuticals (AOLS)
Aeolus Pharmaceuticals (OTC: AOLS) is developing compounds with demonstrated anti-fibrotic, anti-inflammatory, anti-infective and neuro-protective properties. The company's first compound, AEOL 10150, is being developed with funding from the U.S. Department of Health and Human Services, as a medical countermeasure against chemical and radiological weapons, as well as a treatment for pulmonary fibrosis. Aeolus' strategy is to leverage the substantial investment in toxicology, manufacturing and preclinical and clinical studies of AEOL 10150 made by U.S. government agencies, including the contract with BARDA, to efficiently develop the compound for use in idiopathic pulmonary fibrosis and oncology. For more information, visit the company's website at www.aolsrx.com.
TapImmune (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company's peptide or nucleic acid-based immunotherapeutics comprise one or more naturally processed epitopes designed to comprehensively stimulate patients' T-cells while restoring or further augmenting antigen presentation. TapImmune's technologies are suitable for use as stand-alone medications, as well as in combination with current treatment modalities. For more information, visit the company's website at www.tapimmune.com.
Cesca Therapeutics (KOOL)
Cesca Therapeutics (NASDAQ: KOOL) is engaged in the research, development and commercialization of cellular therapeutics and devices for use in regenerative medicine and hematological and oncological applications. The company's technologies address cellular therapeutics, medical/diagnostic devices, cell manufacturing and cryopreservation. Along with its proprietary automated devices for concentration of therapeutic stem cells from blood, Cesca is currently undertaking an FDA-approved pivotal trial to treat late stage critical limb ischemia (CLI) with its SurgWerks™ Platform for the delivery of regenerative cell therapy for vascular disease and orthopedic indications. For more information, visit the company's website at www.cescatherapeutics.com.
Apivio Systems (APVVF)
Apivio Systems (OTC: APVVF) is a Canadian technology company engaged in the design, development, marketing, and sale of communications equipment and software. It has a wholly owned Korean subsidiary with a history of supplying VoIP telephone equipment and other products to major Korean and international telecommunications carriers. The company develops Carrier grade VoIP phones for enterprise and residential markets and distributes them on ODM/OEM basis. Currently, Apivio is launching new product lines including its Android-based enterprise phone marketed with NEC America and portable Wi-Fi phones being sold through carriers and dealers. For more information, visit the company's website at www.apivio.com.
ATA (NASDAQ: ATAI) provides advanced testing technologies in China. The company offers comprehensive services for the creation and delivery of assessments based on its proprietary testing technologies and test delivery platform. ATA's testing technologies are used for professional licensure and certification tests in various industries, including information technology services, banking, teaching, asset management, insurance, and accounting. As of December 31, 2015, ATA's test center network comprised 3,250 authorized test centers located throughout China. The company believes it has the largest test center network of any commercial testing service provider in China. For more information, visit the company's website at www.atai.net.cn.
Orion Energy Systems (OESX)
Orion Energy Systems (NASDAQ: OESX) is engaged in the transformation of commercial and industrial buildings with state-of-the-art energy efficient lighting systems and retrofit lighting solutions. Orion manufactures and markets a cutting edge portfolio of products encompassing LED Solid-State Lighting and high intensity fluorescent lighting. Many of the company's 100+ granted patents and pending patent applications relate to lighting systems that provide exceptional optical and thermal performance, which drive financial, environmental, and work-space benefits for a wide variety of customers in the retrofit markets. For more information, visit the company's website at www.oriones.com.
Atossa Genetics (ATOS)
Atossa Genetics (NASDAQ: ATOS) is a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions. The company's leading pharmaceutical under development is Afimoxifene Topical Gel, or AfTG, which is in phase II clinical development. Atossa is also planning a phase II clinical trial using its patented intraductal Microcatheters to deliver fulvestrant to treat ductal carcinoma in-situ, or DCIS, and breast cancer. For more information, visit the company's website at www.atossagenetics.com.
Petro River Oil (PTRC)
Petro River Oil (OTC: PTRC) is an independent energy company focused on the exploration and development of conventional oil and gas assets. The company recently completed a corporate reorganization, including the addition of new management, the acquisition of several promising new assets, and an infusion of cash. Petro River is taking advantage of the downturn in oil prices to enter highly prospective plays with industry-leading partners. For more information, visit the company's website at www.petroriveroil.com.
Inuvo (NYSE: INUV) is an advertising technology and digital publishing business that serves hundreds of millions of income generating ads monthly across a network of websites and apps serving desktop, tablet and mobile devices. For more information, visit the company's website at www.inuvo.com.
IntelliPharmaCeutics International (IPCI)
IntelliPharmaCeutics International (NASDAQ:IPCI) is a pharmaceutical company specializing in the R&D and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The company's patented Hypermatrix™ technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Based on this technology platform, Intellipharmaceutics has developed several drug delivery systems and a pipeline of products (which have received final FDA approval) and product candidates in various stages of development, including ANDAs filed with the FDA (and one ANDS filed with Health Canada) in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain. For more information, visit the company's website at www.intellipharmaceutics.com.
Nano Dimension (NNDM)
Nano Dimension (NASDAQ: NNDM) is focused on the development of advanced 3D printed electronics systems and advanced additive manufacturing. Nano Dimension's unique products combine three advanced technologies: 3D inkjet, 3D software and nanomaterials. Nano Dimension's novel and proprietary technologies enable the use of conductive and dielectric inks for ultra-rapid prototyping of complex, high-performance multilayer circuit boards. Its primary products include the first 3D printer dedicated to printing multi-layer PCBs (printed circuit boards) and advanced nanotechnology-based conductive and dielectric inks. For more information, visit the company's website at www.nano-di.com.
Neurometrix (NASDAQ: NURO) is an innovative health-care company that develops wearable medical technology and point-of-care test that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company's expertise in biomedical engineering has been refined over nearly two decades of designing, building and marketing medical devices that stimulate nerves and analyze nerve response for diagnostic and therapeutic purposes. NeuroMetrix created the market for point-of-care nerve testing and was first to market with sophisticated, wearable technology for management of chronic pain. For more information, visit the company's website at www.neurometrix.com.
Omni-Lite Industries (OLNCF)
Omni-Lite Industries (OTC: OLNCF) is an R&D company specializing in the manufacture of precision components forged from advanced composite and other alloyed materials. These components are produced utilizing computer-controlled cold-forging systems that are networked to provide an optimal environment for engineering enhancement and optimize production efficiencies. The company operates four business segments: Military, Aerospace, Specialty Automotive, and Sports and Recreational. Its customers are Fortune 500 companies including Boeing, Airbus, Bombardier, Embraer, Ford, Borg Warner, Chrysler, the U.S. Military, and Nike. For more information, visit the company's website at www.omni-lite.com.
Firsthand Technology Value Fund (SVVC)
Firsthand Technology Value Fund (NASDAQ: SVVC) provides private technology and cleantech companies with venture funding and working capital, primarily in the form of equity investments. The Fund invests in companies in various stages of maturity with the goal of achieving profitable exits via IPO or acquisition. To date, our successful exits include Facebook (NASDAQ: FB), Twitter (NYSE: TWTR), SolarCity (NASDAQ: SCTY), and Yelp (NYSE: YELP). Firsthand is led by Kevin Landis, a seasoned technology and cleantech investor with more than 25 years of experience in technology and investment management. For more information, visit the company's website at www.firsthandtvf.com.
Akers Biosciences (AKER)
Akers Biosciences (NASDAQ: AKER) was founded in 1989 with the objective of developing proprietary, in vitro diagnostic technologies that accelerate the rate at which clinicians, and in some cases consumers, can obtain health information. The tests and sample preparation devices that emerge from the company's rapid technology platforms are designed to provide the same level of accuracy as traditional laboratory testing methods, but at a fraction of the cost and turn-around time. Akers Biosciences is dedicated to the development of time- and cost-efficient, single-use devices that can be utilized almost anytime, anywhere. For more information, visit the company's website at www.akersbio.com.
Great Basin Scientific (GBSN)
Great Basin Scientific (NASDAQ: GBSN) is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. Great Basin's vision is to make molecular diagnostic testing simple and cost-effective enough that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. For more information, visit the company's website at www.gbscience.com.
Destiny Media Technologies (DSNY)
Destiny Media Technologies (OTC: DSNY) provides services that enable content owners to securely display and distribute their audio and video content digitally through the Internet. The company's two major services are Clipstream®(www.clipstream.com) and Play MPE® (www.plaympe.com). Clipstream is an automated high availability self-service hosting service protected by two dozen pending and granted patents and is much more secure and flexible than standard video approaches. Play MPE® provides a standardized method to securely and cost effectively distributes pre-release music to radio stations and other music industry professionals, before it is ready for sale. It is protected by granted security and watermark patents. For more information, visit the company's website at www.dsny.com.
Biotricity (OTC: BTCY) is a medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. The company's R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. Biotricity aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system. For more information, visit the company's website at www.biotricity.com.
American Shared Hospital Services (AMS)
American Shared Hospital Services (NYSE: AMS) provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. The company is a leading provider of Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). AMS also offers proton therapy, the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the 21st CenturySM concept. AMS owns a common stock investment in Mevion Medical Systems, Inc., developer of the compact MEVION S250 Proton Therapy System. For more information, visit the company's website at www.ashs.com.
Cemtrex (NASDAQ: CETX) is a global, diversified industrial and manufacturing company that provides a wide array of solutions designed to address today's technology challenges. The company is rapidly growing through acquisitions. Cemtrex provides manufacturing services of advanced custom engineered electronics, industrial contracting services, monitoring instruments for industrial processes and environmental compliance, and equipment for controlling particulates, hazardous pollutants, and greenhouse gases used in carbon trading globally. For more information, visit the company's website at www.cemtrex.com.
Long Island Iced Tea Corp. (LTEA)
Long Island Iced Tea Corp. (OTC: LTEA) operates in the ready-to-drink tea segment of the beverage industry via its non-alcoholic, premium iced tea bottled beverages. The company is currently organized around its flagship brand, Long Island Iced Tea, a premium, ready-to-drink, proprietary recipe iced tea sold primarily through a network of national and regional retail chains and distributors focused on the East Coast of the United States. For more information, visit the company's website at www.longislandicedtea.com.
Simulation Plus (SLP)
Simulation Plus (NASDAQ: SLP) develops drug discovery and development software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. The company integrates new and existing science in medicinal chemistry, computational chemistry, pharmaceutical science, biology, and physiology into its software for physiologically based pharmacokinetic modeling and simulation. The company also provides both preclinical and clinical pharmacometric consulting services for regulatory submissions. For more information, visit the company's website at www.simulations-plus.com.
Stellar Biotech (SBOT)
Stellar Biotech (NASDAQ: SBOT) manufactures and sells Keyhole Limpet Hemocyanin (KLH) protein in the field of immunotherapy. KLH is an important immune-stimulating molecule widely used as an active pharmaceutical ingredient in many new immunotherapies, and as an injectable product to assess immune response. Stellar's customers and partners include multinational pharmaceutical companies, renowned research centers, and developers of active immunotherapies and therapeutic vaccines. The complexity and versatility of the KLH molecule, and growing need for commercial-scale GMP grade KLH, provide numerous commercial opportunities. For more information, visit the company's website at www.stellarbiotechnologies.com.
Integrity Applications (IGAP)
Integrity Applications (OTC: IGAP) is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes. Integrity Applications operates primarily through its wholly owned Israeli subsidiary, A.D. Integrity Applications, Ltd. The company has developed the GlucoTrack® model DF-F, a technology intended for use in non-invasive quantitative spot measurement of glucose, for home-use. The GlucoTrack model DF-F has been proven for safety and performances for patients in clinical studies conducted by third party, under the supervision of leading diabetes authorities at the Soroka University Medical Center in Israel. The upgraded device gained a CE-Mark approval in December 2015. For more information, visit the company's website at www.integrity-app.com.
NXT Energy Solutions (NSFDF)
NXT Energy Solutions is a Calgary-based company whose proprietary Stress Field Detection ("SFD®") survey system utilizes quantum-scale sensors to detect gravity field perturbations in an airborne survey method which can be used both onshore and offshore to remotely identify areas with exploration potential for traps and reservoirs. The SFD® survey system enables clients to focus their hydrocarbon exploration decisions concerning land commitments, data acquisition expenditures and prospect prioritization on areas with the greatest potential. SFD® is environmentally friendly and unaffected by ground security issues or difficult terrain, and is the registered trademark of NXT Energy Solutions Inc. For more information, visit the company's website at www.nxtenergy.com.
Catasys (OTC: CATS) is a provider of big data-based analytics and predictive modeling driven behavioral healthcare services to health plans and their members through its OnTrak program. OnTrak is designed to improve member health and, at the same time, lower costs to the insurer for underserved populations where behavioral health conditions cause or exacerbate co-existing medical conditions. The program utilizes proprietary analytics and proprietary enrollment, engagement and behavioral modification capabilities to assist members who otherwise do not seek care through a patient-centric treatment that integrates evidence-based medical and psychosocial interventions. For more information, visit the company's website at www.catasys.com.
Willdan Group (WLDN)
Willdan Group (NASDAQ: WLDN) provides professional consulting and technical services to utilities, public agencies and private industry throughout the United States. The company's service offerings span a broad set of complementary disciplines that include energy efficiency and sustainability, engineering and planning, financial and economic consulting, and national preparedness. Willdan provides integrated technical solutions to extend the reach and resources of its clients, and provides all services through its subsidiaries specialized in each segment. For more information, visit the company's website at www.willdan.com.
Telkonet (OTC: TKOI) is an energy management technology provider offering hardware, software and services to commercial customers throughout the world. The company's complementary business divisions include EcoSmart, an energy management technology platform featuring recovery time technology; and EthoStream, one of the largest hospitality high-speed internet access networks in the world. Telkonet serves vertical markets in hospitality, education, military, government, healthcare and public housing. For more information, visit the company's website at www.telkonet.com.
PCM (NASDAQ: PCMI) (formerly known as PC Mall, Inc.) is a technology solutions provider to businesses, government and educational institutions and individual consumers. The company markets its products, services and solutions through a 700+ sales force, field service teams, and various direct marketing techniques. PCM offers multi-branded hardware solutions with a high degree of customization, and also facilitates an efficient supply chain and support mechanism for manufacturers by using a combination of direct marketing, centralized selling and support, and centralized product fulfillment. For more information, visit the company's website at www.pcm.com.
Galectin Therapeutics (GALT)
Galectin Therapeutics (NASDAQ: GALT) is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the company's unique understanding of galectin proteins, which are key mediators of biologic function. The company seeks to leverage extensive scientific and development expertise, as well as established relationships with external sources to achieve cost-effective and efficient development. Galectin is pursuing a development pathway to clinical enhancement and commercialization for its lead compounds in liver fibrosis and cancer. For more information, visit the company's website at www.galectintherapeutics.com.
Advanced Medical Isotope (ADMD)
Advanced Medical Isotope (OTC: ADMD) is a late-stage radiation oncology-focused medical device company developing yttrium-90-based brachytherapy devices for the treatment of non-resectable tumors. The company's IsoPet Solutions division is focused on establishing the infrastructure necessary to provide its product to veterinary clinics, as well as providing product awareness and education to veterinary oncologists. Advanced Medical Isotope intends to outsource material aspects of manufacturing, distribution, sales and marketing for its products in the United States and to enter into licensing arrangements outside of the United States, though the company will evaluate its alternatives before finalizing its plans. For more information, visit the company's website at www.isotopeworld.com.
Theralase (OTC: TLTFF) designs, manufactures and markets patented super-pulsed laser technology indicated for the elimination of pain, reduction of inflammation and dramatic acceleration of tissue healing for numerous nerve, muscle and joint conditions. Theralase's Photo Dynamic Therapy ("PDT") Division researches and develops specially designed molecules called Photo Dynamic Compounds ("PDCs"), which are able to localize to cancer cells and then when laser light activated, effectively destroy them. For more information, visit the company's website at www.theralase.com.
Auxilio (OTC: AUXO) provides Managed Print Services (MPS) and IT Security for the healthcare industry. The company serves a national portfolio of nearly 220 hospital campuses and manages over 1.5 billion documents annually from over 90,000 devices, supporting over 280,000 caregivers. Through its Cyber Security Professional Services Group, Auxilio subsidiary Redspin provides an end-to-end security offering that specifically addresses hospital security challenges or when a breach has occurred. This complete service offering of Redspin is unique to the marketplace and helps ensure enterprise-wide security and improved patient experiences through its ability to mitigate risk and improve efficiency across the hospital or health system. For more information, visit the company's website at www.auxilioinc.com.
Social Reality (SCRI)
Social Reality (OTC: SCRI) is an Internet advertising and platform technology company. The company builds and leverages partner technologies that service social media and the real-time bidding markets to improve advertising performance for brands, agencies and publishers across all digital platforms. Its advertising services utilize data from platforms, including Facebook, Yahoo, LinkedIn, and Google to optimize digital advertising. In addition, it creates applications as custom programs and builds them on a campaign-by-campaign basis, as well as offers them on a managed or self-service subscription basis through its GroupAd platform. For more information, visit the company's website at www.socialreality.com.
Cellceutix (OTC: CTIX) is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Cellceutix's anti-cancer drug Kevetrin concluded a phase 1 clinical trial, and the company is now preparing its FDA application for a phase 2 ovarian cancer study. Cellceutix is in a phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of Oral Mucositis in patients with head and neck cancer. The company's anti-psoriasis drug Prurisol concluded a phase 2 trial, data is still blinded. Cellceutix's lead antibiotic, Brilacidin, has completed a phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. For more information, visit the company's website at www.cellceutix.com.
Biostage (NASDAQ: BSTG) is a biotech company in the emerging field of regenerative medicine. The company's goal is to regenerate and restore organ function of the esophagus, trachea or bronchus damaged by cancer, trauma, infection or congenital diseases. Using its Cellframe technology, Biostage has been developing a new generation of organ implants capable of being used in the esophagus and main airways (trachea and bronchi). The company is expanding its preclinical data in collaboration with the Mayo Clinic and intends to submit an IND with the FDA for its first indication in 2016. For more information, visit the company's website at www.biostage.com.
Lingo Media (LMDCF)
Lingo Media (OTC: LMDCF) is a global EdTech company developing and marketing products for learners of English through various life stages. By integrating education and technology, the company empowers English language educators to easily transition from traditional teaching methods to digital learning. Lingo Media provides online and print-based solutions through two distinct business units: ELL Technologies and Lingo Learning. ELL Technologies provides online training and assessment for English language learning, while Lingo Learning is a print-based publisher of English language learning programs in China. For more information, visit the company's website at www.lingomedia.com.
Diamcor Mining (DMIFF)
Diamcor Mining (OTC: DMIFF) is a junior diamond mining company a well-established operational and production history in South Africa and extensive prior experience supplying rough diamonds to the world market. In March of 2011 the Company established a long-term strategic alliance with world famous luxury retailer Tiffany & Co. and is now in the final stages of developing the near-term production capable Krone-Endora at Venetia Project ("Krone-Endora"or "the Project"). Krone-Endora was successfully acquired from DeBeers in February of 2011 and is located directly adjacent to the third largest diamond mine in the world, DeBeers flagship Venetia Mine. For more information, visit the company's website at www.diamcormining.com.
Relmada Therapeutics (RLMD)
Relmada Therapeutics (OTC: RLMD) is a clinical-stage specialty pharmaceutical company developing novel versions of proven drug products as well as new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. The company's portfolio includes: d-Methadone (REL-1017), its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. For more information, please visit the company's website at: www.relmada.com.
Inventergy Global (INVT)
Inventergy Global (NASDAQ: INVT) is an intellectual property company focused on identifying, acquiring and licensing the patented technologies of market-significant technology leaders. The company leans on decades of corporate experience, market and technology expertise, and industry connections to help clients leverage the value of their innovations to achieve greater returns. Inventergy acquires portfolios in the telecommunications industry, primarily in IP multimedia subsystems and voice over IP, and mobile broadband communications segments. For more information, visit the company's website at www.inventergy.com.
BioSig Technologies (BSGM)
BioSig Technologies (OTC: BSGM) is a medical device company preparing to commercialize its PURE EP System, a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to provide high-fidelity cardiac signal recordings and enhanced data. The company has achieved proof-of-concept and has performed preclinical studies at the Mayo Clinic in Minnesota. BioSig is collaborating with several of the nation's most prestigious cardiac arrhythmia centers to develop, refine and, ultimately, commercialize the PURE EP System. For more information, visit the company's website at www.biosigtech.com.
Rennova Health (RNVA)
Rennova Health (NASDAQ: RNVA) is a vertically integrated public healthcare holding company focused on serving essential healthcare categories, especially those with unmet needs and significant opportunities for innovation-driven solutions. The company develops and operates forward-thinking businesses, systems and services to support better treatment outcomes, more cost-effective patient care, and optimized revenue streams. Rennova's diverse solutions include diagnostic laboratory testing and analytics for precision medicine, specialized and streamlined EHRs and other essential software services, and comprehensive medical billing and financial services for enhanced revenue cycle management. For more information, visit the company's website at www.rennovahealth.com.
HealthWarehouse.com (OTC: HEWA) is focused on the out-of-pocket prescription drug market, which is expected to grow to more than $80 billion in 2016. HealthWarehouse.com is currently one of less than 45 Verified Internet Pharmacy Practice Websites ("VIPPS") accredited by the National Association of Boards of Pharmacy, and is the only VIPPS accredited pharmacy licensed in all 50 states that processes out-of-pocket prescriptions online. The company is a four-time winner of the BizRate Circle of Excellence Award for outstanding customer service and satisfaction, and was recognized by major consumer publications as having the lowest price among top U.S. pharmacies for commonly prescribed medications. For more information, visit the company's website at www.healthwarehouse.com.
iCAD (NASDAQ: ICAD) delivers innovative cancer detection, radiation therapy solutions, and management services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. iCAD offers a variety of upgradeable, computer aided detection (CAD) and workflow solutions to support breast, prostate and colorectal cancers. iCAD's Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a non-invasive technology that targets cancer while decreasing exposure to surrounding healthy tissue. For more information, visit the company's website at www.icadmed.com.
Sunworks (NASDAQ: SUNW) designs, installs and manages solar power systems for commercial, agricultural and residential customers. Sunworks (formerly Solar3D) is one of the fastest growing solar systems providers in the western United States, delivering 2.5 kilowatt to multi-megawatt commercial systems. The company's mission is to further the widespread adoption of solar power by deploying affordable, state-of-the-art systems and developing breakthrough new solar technologies. For more information, visit the company's website at www.sunworksusa.com.
Foundation HealthCare (FDNH)
Foundation HealthCare (OTC: FDNH) owns and operates surgical hospitals including ancillary hospital-based services. These additional services include hyperbaric medicine, sleep labs, intra-operative monitoring, imaging and robotic surgery. The company is also a chief ASC management and development company focused on partnering with physicians and employees to create an outstanding patient experience while maximizing partner and shareholder value. Foundation HealthCare is at the forefront of offering turnkey management and development solutions for physician partners. For more information, visit the company's website at www.fdnh.com.
OpGen (NASDAQ: OPGN) is developing and deploying precision medicine tools for antibiotic stewardship management in global healthcare settings, adding real benefits to antimicrobial stewardship programs and assisting clinicians with more rapid information about life threatening infections. Using molecular testing and bioinformatics, OpGen offers a full portfolio of QuickFISH and Acuitas products including the MDRO Gene Test, the Resistome Test, microbial Whole Genome Sequence Analysis, and Acuitas Lighthouse MDRO Management System products. Its QuickFISH products are a suite of FDA-cleared and CE-marked diagnostics for rapid molecular testing of positive blood cultures designed to assure appropriate antibiotic therapy. For more information, visit the company's website at www.opgen.com.
Centric Health (CHHHF)
Centric Health (OTC: CHHHF) is a healthcare company operating through two core divisions: Specialty Pharmacy and Surgical & Medical Centres. With national networks of facilities in each of its businesses, deep knowledge and experience of healthcare delivery and extensive, trusted relationships with payers, physicians, and government agencies, the company is positioned to address current and future healthcare needs in growing markets as the Canadian healthcare industry continues to evolve over the medium to long term. For more information, visit the company's website at www.centrichealth.ca.
Oxis International (OXIS)
Oxis International (OTC: OXIS) operates through a wholly owned subsidiary, Oxis Biotech, Inc., to develop immunotherapies for the treatment of cancer and other unmet medical needs. The company's OXS-2175 candidate targets the treatment of triple-negative breast cancer. OXS-1550 targets cancer cells expressing the CD19 receptor or CD22 receptor or both receptors. When OXS-1550 binds to cancer cells, the cancer cells internalize OXS-1550 and are killed due to the action of drug's cytotoxic payload. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. OXS-4235, also a small molecule therapeutic candidate, targets the treatment of multiple myeloma and associated osteolytic lesions. For more information, visit the company's website at www.oxis.com.
LabStyle Innovations Corp. (DRIO)
LabStyle Innovations Corp. (NASDAQ: DRIO) creates innovative mobile and digital tools that empower and engage users to lead healthier lives. LabStyle's flagship product, The Dario™ Smart Diabetes Management Solution, is a platform for diabetes management that combines an all-in-one blood glucose meter, native smart phone app (iOS & Android), website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and healthcare systems. For more information, visit the company's website at www.mydario.com.
Trans-Lux (OTC: TNLX) is a global supplier of engaging LED-based digital display solutions and lighting for a wide range of business, sports, residential and government applications. Trans-Lux delivers truly integrated LED display and lighting solutions designed to transform venues into events with the highest levels of performance and cost-efficiency. A single source global solution provider, Trans-Lux designs, manufactures, markets and services LED display and lighting solutions. For more information, visit the company's website at www.trans-lux.com.
Perma-Fix Environmental Services (PESI)
Perma-Fix Environmental Services (NASDAQ: PESI) is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals, research labs and institutions, federal agencies, including the Department of Energy, the Department of Defense, and the commercial nuclear industry. Perma-Fix's nuclear services group provides project management, waste management, environmental restoration, decontamination and decommissioning, new build construction, and radiological protection, safety and industrial hygiene capability to its clients. For more information, visit the company's website at www.perma-fix.com.
Bucha (ABRW), founded in 2010, is an award-winning craft brewer. In the second quarter of 2015, the company acquired 100% of the assets of Búcha® Live Kombucha from B&R Liquid Adventure, LLC for a combination of cash and stock. On October 7, 2015, American Brewing sold 100% of its beer assets, improving its balance sheet and providing working capital to expand its healthy beverage business. For more information, visit the company's website at www.americanbrewing.com.
XFit Brands (XFTB)
XFit Brands (OTC: XFTB) is a supplier of functional fitness brands, products and equipment sold at retail and fitness outlets worldwide. XFit provides a portfolio of products and services spanning MMA, CrossFit, and other high- and low-impact fitness regimes. The company also owns the trademarks XFIT® for its Functional Fitness line, Throwdown® for its MMA portfolio, and Transformations® in programming. The company's portfolio of brands and products are sold in over 20 countries and supply many of the leading gym and health club organizations in the United States. For more information, visit the company's website at www.xfitbrands.com.
IDW Media Holdings (IDWM)
IDW Media Holdings (OTC: IDWM) operates as a holding company with interest in providing digital media and print-based solutions. The company operates through flowing segments: CTM Media Group, and Idea & Design Works, LLC. The CTM Media Group segment provides brochure distribution, publishing, rightcard, and digital distribution. The IDW segment is a comic book and graphic novel publisher that creates and licenses intellectual property. For more information, visit the company's website at www.idwmediaholdings.com.
Optex Systems Holdings (OPXS)
Optex Systems Holdings (OPXS) was founded in 1987. The Richardson, Texas-based ISO 9001:2008 certified concern manufactures optical sighting systems and assemblies, primarily for Department of Defense (DOD) applications. The company's products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles, light armored and armored security vehicles, and have been selected for installation on the Stryker family of vehicles. Optex also manufactures and delivers numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Optex delivers its products both directly to the military services and to prime contractors. For more information, visit the company's website at www.optexsys.com.
Reign Sapphire (RGNP)
Reign Sapphire (OTC: RGNP) is a "miners-gate to retail" company that sells sapphires--rough sapphires to finished jewelry; a color gemstone brand; and a jewelry brand featuring Australian sapphires. The company was founded on the concept of focusing in on a singular gemstone, while maintaining an ethically produced process. Reign Sapphires are guaranteed natural, guaranteed Australian, mined in an environmentally friendly manner, ethically processed with jewelry manufactured in the USA. For more information, visit the company's website at www.reignsc.com.
Smith Micro Software (SMSI)
Smith Micro Software's (NASDAQ: SMSI) portfolio of wireless solutions includes a range of client and server applications that manage voice, data, video and connectivity over mobile broadband networks. The company's primary customers include mobile network operators, mobile device manufacturers and enterprise businesses. In addition to its wireless and mobility software, Smith Micro offers personal productivity and graphics products distributed through a variety of consumer channels worldwide. Smith Micro Software operates in two business segments: Wireless and Productivity & Graphics. The company primarily delivers its software via electronic downloads. For more information, visit the company's website at www.smithmicro.com.
Energy Fuels (UUUU)
Energy Fuels (NYSE: UUUU) is an integrated U.S.-based uranium mining company supplying U3O8 to major nuclear utilities. The company operates two of America's key uranium production centers: the White Mesa Mill in Utah, the only conventional uranium mill operating in the U.S. today and has a licensed capacity of over 8 million pounds of U3O8 per year; and the Nichols Ranch Processing Facility in Wyoming, an in situ recovery ("ISR") production center with a licensed capacity of 2 million pounds of U3O8 per year. For more information, visit the company's website at www.energyfuels.com.
Provision Interactive Technologies (PVHO)
Provision Interactive Technologies, a subsidiary of Provision Holding, Inc. (OTC: PVHO), is the leading purveyor of intelligent interactive 3D holographic display technologies, software and integrated solutions for both commercial and consumer-focused applications. Provision's 3D holographic display systems represent a revolutionary technology that provides the projection of full color, high-resolution videos into space detached from the screen, without any special glasses. Provision is currently the market leader in true 3D consumer advertising display products being implemented by innovative, consumer-focused companies. For more information, visit the company's website at www.provision.tv.
Soupman (OTC: SOUP) is a manufacturer and multi-channel marketer of premium soups that are offered under the "Original Soupman" brand to consumers and the food service industry. The company's license from Al Yeganeh, the legendary "soupman," provides the company with access to Mr. Yeganeh's recipes, name, likeness and other intellectual properties. For more information, visit the company's website at www.originalsoupman.com.
Oculus Innovative Sciences (OCLS)
Oculus Innovative Sciences (NASDAQ: OCLS) has designed a humanitarian program to respond to unexpected disasters—floods, earthquakes, tsunamis, hurricanes, epidemics and even man-made calamities—by providing product (such as food or medical assistance) to these victims. The product will be available according to the regulatory claims in each area and at the request of emergency first responders and foundations. To this end, Oculus is proactively seeking partnerships with international aid groups that respond to relief needs and improve global health care services. For more information, visit the company's website at www.oculusis.com.